## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `pt-141-insomnia`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/pt-141-insomnia/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-insomnia/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-insomnia/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-insomnia/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-insomnia/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-insomnia/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `pt-141-insomnia` v2 · content_hash `a892fd44c8102ee6…` · thread_head genesis · 22 DIVs
- **thesis (c1):** No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.
  - c2 [human/active] Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.
  - c3 [human/active] Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.
  - c4 [mechanistic/active] PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.
  - c5 [anecdotal/active] Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-insomnia/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-insomnia/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `pt-141-insomnia`
- **title:** PT-141 for Insomnia: Evidence-Graded Review
- **url:** https://miscsubjects.com/a/pt-141-insomnia
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:07.342Z
- **tags:** peptide, matrix

## Body

## What's breaking down
Insomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.

## Why PT-141 might help you
PT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.

1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.
2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.
3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.

Human data for insomnia itself does not exist. All clinical work focused on sexual desire.

## How these fit together
Single-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.

## What the evidence actually shows
No randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).

Side-effect data from the same program lists “trouble sleeping” as a possible reaction (mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route).

## What scientists say
Researchers describe PT-141 as a melanocortin agonist acting centrally on MC3R/MC4R in the hypothalamus. This mechanism explains effects on sexual motivation. No publications link it to sleep architecture or insomnia treatment. Hypothalamic melanocortin pathways overlap with arousal regulation, but that overlap remains untested for sleep outcomes.

## What people say on Reddit
Anecdotal reports are mixed and sparse. One thread titled “PT-141 and best sleep ever” describes subjectively deeper rest after dosing. Several users note fatigue or 10–12 hours of sleep the night after injection, sometimes with persistent arousal effects upon waking. Others report restlessness or nausea that interferes with sleep. No consistent pattern of insomnia relief appears across threads (examples: reddit.com/r/Peptidesource/comments/1qdmtus, reddit.com/r/erectiledysfunction/comments/15cmlf0).

## What people say on X
Limited public discussion. Posts mentioning PT-141 and sleep are rare and usually incidental to libido use. No verified threads or threads with measurable outcomes surfaced in searches.

## What we do not know
- Whether PT-141 changes sleep latency, efficiency, or architecture in humans.
- Dose-response relationship for any sleep effect.
- Long-term impact on insomnia when used repeatedly.
- Interaction with common insomnia factors such as cortisol rhythm or circadian misalignment.
All claims beyond the established sexual-desire indication remain mechanistic or anecdotal.

## Safety and limits
Common side effects in trials included nausea, flushing, and headache. “Trouble sleeping” appears in prescribing information. PT-141 carries an FDA approval only for hypoactive sexual desire disorder in premenopausal women. No safety data support its use for insomnia. Individual responses vary widely in anecdotal reports.

## Claims (5)

- **c3** [human w=0.8] Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.
  - who_claims: grok/grok-4.3
  - slot: limitations
  - sources: s3
- **c1** [human w=0.8] No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.
  - who_claims: grok/grok-4.3
  - sources: s1, s2
- **c2** [human w=0.8] Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c4** [mechanistic w=0.3] PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.
  - who_claims: grok/grok-4.3
  - sources: s4
- **c5** [anecdotal w=0.3] Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.
  - who_claims: grok/grok-4.3
  - sources: s5, s6

## Voxel graph (5 atoms · 12 edges)
- full graph: https://miscsubjects.com/api/articles/pt-141-insomnia/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (6)
- chain valid: yes · head: `68b103dde713d10e`

### s1 · pubmed · ok
- title: Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
- url: https://pubmed.ncbi.nlm.nih.gov/31599840/
- summary: Phase 3 RECONNECT trial results for HSDD; no sleep endpoints reported.
- quote: Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.
- claim_ids: c1, c2
- hash: `814839b477804ad6`

### s2 · clinical_trial · ok
- title: Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
- url: https://clinicaltrials.gov/study/NCT02338960
- summary: Confirms trial design focused solely on sexual desire.
- quote: Primary Objective: To evaluate the efficacy of bremelanotide (BMT)... for the treatment of HSDD
- claim_ids: c1
- hash: `3ff336a1821e343c`

### s3 · medical · http_403
- title: Bremelanotide (subcutaneous route) - Side effects & dosage
- url: https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805
- summary: Lists trouble sleeping among possible side effects.
- quote: * trouble sleeping
- claim_ids: c3
- hash: `5abe74d91d95c0be`

### s4 · review · http_429
- title: PT-141 for Women: Complete Guide to Bremelanotide
- url: https://www.innerbalance.com/p/learn/pt141-for-women/
- summary: Describes hypothalamic MC4R mechanism.
- quote: PT-141 targets the central nervous system directly, addressing desire at its neurological origin.
- claim_ids: c4
- hash: `07ba452e51ea1a43`

### s5 · reddit · ok
- title: PT-141 and best sleep ever
- url: https://www.reddit.com/r/Peptidesource/comments/1qdmtus/pt141_and_best_sleep_ever/
- summary: User anecdote claiming improved sleep.
- quote: PT-141 is great and I take it every 3 days... the effects last...
- claim_ids: c5
- hash: `d73163b5dd1d7a9b`

### s6 · reddit · ok
- title: PT141 works great but only when sleeping
- url: https://www.reddit.com/r/erectiledysfunction/comments/15cmlf0/pt141_works_great_but_only_when_sleeping/
- summary: Multiple user reports of altered sleep duration or quality.
- quote: I always sleep 12 hours straight after taking it.
- claim_ids: c5
- hash: `68b103dde713d10e`

## Provenance (2 model passes)
- chain valid: yes · head: `8fd312dfb88a3bf2`

- write · grok/grok-4.3 · 2026-06-30T01:14 · hash `0258fe9c0761`
- voxel_divide · owner · 2026-07-17T02:41 · hash `8fd312dfb88a`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/pt-141-insomnia/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/pt-141-insomnia/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-insomnia","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-insomnia|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-insomnia|tier|assertion`
- **iMessage ask:** `pt-141-insomnia|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `pt-141-insomnia`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-insomnia/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-insomnia/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*